跳至主要内容
临床试验/NCT01900314
NCT01900314已完成不适用

Imaging Biomarkers for TMS Treatment of Depression

University of Michigan2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2013年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
Depressive Symptoms at 4 Weeks

研究概览

简要总结

The purpose of this research is to learn more about how rTMS works to reduce the symptoms of depression. This information can be used to improve the effectiveness of the treatment. The study will use functional magnetic resonance imaging (fMRI) to examine changes in brain function after treatment with rTMS. fMRI is a safe and painless technique that allows investigators to observe the brain "at work." The investigators will use fMRI to see what regions of the brain become active when you perform a concentration task and how that activation is changed after rTMS.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
22 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary diagnosis of major depressive disorder
  • Male and female subjects, ages 22-65
  • Have failed at least 1 antidepressant medication at adequate dose and duration
  • On stable antidepressant medication regimen for at least 4 weeks prior to TMS therapy

排除标准

  • Diagnosed with a psychotic, bipolar, obsessive-compulsive or post-traumatic stress disorder
  • Active substance abuse, including alcohol
  • Medical and/or neurological condition that could affect your brain function or risk of seizure, including a stroke, epilepsy, or a closed head injury;
  • No presence of an implanted device like a pacemaker/neurostimulator or metal in the head or body;
  • Pregnant or trying to get pregnant
  • Failed to respond to an adequate course of electroconvulsive therapy (ECT)
  • Previous treatment with TMS
  • Current depressive episode longer than 5 years

结局指标

主要结局

Depressive Symptoms at 4 Weeks

时间窗: 4 weeks after baseline

MADRS: Montgomery Asberg Depression Rating Scale Range: 0 - 60 0 to 6 - normal/symptom absent 7 to 19 - mild depression 20 to 34 - moderate depression \>34 - severe depression

次要结局

  • Depression Symptoms at 4 Weeks- Secondary(4 weeks after baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stephan Taylor

Professor of Psychiatry

University of Michigan

研究点 (2)

Loading locations...

相似试验

Imaging Biomarkers for TMS Treatment of Depression | 临床试验